{"id":5881,"date":"2026-03-31T15:08:16","date_gmt":"2026-03-31T15:08:16","guid":{"rendered":"https:\/\/regenerated.health\/ibs-c-vs-ibs-d\/"},"modified":"2026-07-06T17:06:25","modified_gmt":"2026-07-06T17:06:25","slug":"ibs-c-vs-ibs-d","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/ibs-c-vs-ibs-d\/","title":{"rendered":"&#8220;IBS-C vs IBS-D: How Subtype Affects Your Treatment Plan&#8221;"},"content":{"rendered":"<div class=\"at-a-glance\">\n<h2>At a Glance<\/h2>\n<ul>\n<li>IBS is classified into four subtypes based on stool patterns: IBS-C (constipation), IBS-D (diarrhea), IBS-M (mixed), and IBS-U (unsubtyped), and each responds to different treatments.<\/li>\n<li>The Bristol Stool Form Scale and Rome IV criteria are the standard tools doctors use to determine your subtype.<\/li>\n<li>IBS-C responds well to linaclotide, lubiprostone, and osmotic laxatives, while IBS-D is better treated with loperamide, eluxadoline, rifaximin, or bile acid sequestrants.<\/li>\n<li>Dietary strategies differ too: IBS-D patients often benefit from reducing insoluble fiber and caffeine, while IBS-C patients generally need more soluble fiber and hydration.<\/li>\n<li>Your subtype can shift over time, and roughly one-third of patients alternate between constipation and diarrhea patterns within the same year.<\/li>\n<\/ul>\n<\/div>\n<h2>Why Your IBS Subtype Matters More Than You Think<\/h2>\n<p>Telling someone you have IBS is a bit like telling them you have a headache. It&#8217;s true, but it doesn&#8217;t say much about what&#8217;s actually happening or what will help. The experience of someone who hasn&#8217;t had a bowel movement in five days is fundamentally different from someone who has already rushed to the bathroom three times before lunch. Yet both carry the same diagnosis.<\/p>\n<p>That&#8217;s why subtyping exists. Your IBS subtype determines which medications are appropriate, which dietary changes are likely to help, and even which underlying mechanisms may be driving your symptoms. Getting this right is the first step toward treatment that actually works rather than a generic plan pulled from a pamphlet.<\/p>\n<h2>Understanding the Four Subtypes<\/h2>\n<h3>How Rome IV Classifies IBS<\/h3>\n<p>The Rome IV criteria, the current diagnostic standard for functional gastrointestinal disorders, define IBS as recurrent abdominal pain at least one day per week in the last three months, associated with changes in stool frequency or form [1]. Once the diagnosis is established, subtyping is based on your predominant stool pattern on days when your bowels are abnormal:<\/p>\n<p><strong>IBS-C (Constipation-predominant):<\/strong> More than 25% of bowel movements are hard or lumpy (Bristol types 1-2), and fewer than 25% are loose or watery.<\/p>\n<p><strong>IBS-D (Diarrhea-predominant):<\/strong> More than 25% of bowel movements are loose or watery (Bristol types 6-7), and fewer than 25% are hard or lumpy.<\/p>\n<p><strong>IBS-M (Mixed):<\/strong> More than 25% of bowel movements are hard\/lumpy AND more than 25% are loose\/watery.<\/p>\n<p><strong>IBS-U (Unsubtyped):<\/strong> Meets IBS criteria but stool patterns don&#8217;t fit neatly into the other categories.<\/p>\n<h3>The Bristol Stool Form Scale<\/h3>\n<p>The Bristol Stool Form Scale is a visual chart that classifies stool into seven types, from Type 1 (separate hard lumps, like nuts) to Type 7 (entirely liquid). Types 3 and 4 are considered normal. Your doctor may ask you to track your stool type over two to four weeks using this scale to determine your subtype accurately [2].<\/p>\n<p>This isn&#8217;t just an academic exercise. The Bristol scale directly influences treatment decisions. A patient who reports &#8220;constipation&#8221; but actually produces Type 3-4 stools infrequently has a different problem than someone passing Type 1 stools with significant straining. The scale creates a shared language between you and your provider.<\/p>\n<h2>IBS-C: When Constipation Is the Main Problem<\/h2>\n<h3>What&#8217;s Happening in Your Gut<\/h3>\n<p>IBS-C involves slowed colonic transit, meaning stool moves through your large intestine more slowly than it should. The longer stool sits in the colon, the more water gets absorbed, producing hard, dry, difficult-to-pass bowel movements. But IBS-C is not just constipation. The abdominal pain, bloating, and discomfort distinguish it from simple functional constipation [3].<\/p>\n<p>Visceral hypersensitivity plays a role too. The nerves in your gut may be extra responsive to normal stretching and distension, which is why bloating can feel genuinely painful rather than just uncomfortable.<\/p>\n<h3>Medications for IBS-C<\/h3>\n<p><strong>Linaclotide (Linzess):<\/strong> This is often the first prescription option. It works by activating receptors on the intestinal lining that increase fluid secretion and speed transit. It also has a direct analgesic effect on visceral pain nerves. Clinical trials showed significant improvement in both constipation and abdominal pain compared to placebo [4]. Take it on an empty stomach, at least 30 minutes before breakfast.<\/p>\n<p><strong>Plecanatide (Trulance):<\/strong> Works through a similar mechanism to linaclotide but mimics a natural gut peptide called uroguanylin. Some patients tolerate it better. It can be taken with or without food [5].<\/p>\n<p><strong>Lubiprostone (Amitiza):<\/strong> A chloride channel activator that increases intestinal fluid. It&#8217;s been available since 2006 and has a well-established safety record. Nausea is the most common side effect, and taking it with food helps [6].<\/p>\n<p><strong>Tegaserod (Zelnorm):<\/strong> This serotonin receptor agonist was re-approved in 2019 for women under 65 with IBS-C. It speeds colonic transit and reduces visceral sensitivity. Due to earlier cardiovascular concerns, it&#8217;s restricted to patients without significant cardiac risk factors [7].<\/p>\n<p><strong>Osmotic laxatives:<\/strong> Polyethylene glycol (MiraLAX) is commonly used as a first-line option. It helps with constipation but hasn&#8217;t been shown to improve IBS-related pain or bloating, so it works best as part of a combination approach [8].<\/p>\n<h3>Dietary Tips for IBS-C<\/h3>\n<p>Soluble fiber is your friend. Psyllium husk (Metamucil) at doses of 5 to 10 grams daily draws water into the stool and forms a gel that eases transit. Increase gradually to avoid worsening bloating. Adequate hydration matters too, as fiber without water can make constipation worse.<\/p>\n<p>Kiwifruit (two green kiwis daily) has surprisingly good evidence for improving stool frequency and consistency. A randomized trial found it outperformed psyllium for overall satisfaction [9]. The combination of fiber, water, and actinidin (a natural enzyme) appears to be responsible.<\/p>\n<h2>IBS-D: When Diarrhea Runs the Show<\/h2>\n<h3>What&#8217;s Happening in Your Gut<\/h3>\n<p>IBS-D involves faster colonic transit, increased intestinal secretion, and often heightened sensitivity to bile acids. Up to one-third of IBS-D patients may have bile acid malabsorption (BAM), where excess bile acids reach the colon and trigger fluid secretion and rapid motility [10]. This is worth investigating because bile acid sequestrants are a targeted treatment.<\/p>\n<p>The urgency that comes with IBS-D is often the most disabling symptom. It&#8217;s not just loose stools; it&#8217;s the anxiety of needing a bathroom immediately, which can lead to avoidance of travel, social events, and eating out.<\/p>\n<h3>Medications for IBS-D<\/h3>\n<p><strong>Loperamide (Imodium):<\/strong> The classic first-line option. It slows gut motility and reduces stool frequency. It doesn&#8217;t help with pain or bloating, but for urgent diarrhea, it&#8217;s reliable and well-tolerated. Some patients use it preventively before situations where bathroom access is uncertain [11].<\/p>\n<p><strong>Eluxadoline (Viberzi):<\/strong> This acts on multiple opioid receptors in the gut to reduce motility and visceral pain without the central effects of traditional opioids. Phase III trials showed significant improvements in both stool consistency and abdominal pain [12]. It&#8217;s contraindicated in patients without a gallbladder due to a small risk of sphincter of Oddi spasm and pancreatitis.<\/p>\n<p><strong>Rifaximin (Xifaxan):<\/strong> A gut-targeted antibiotic shown to improve overall IBS-D symptoms, especially bloating. The standard course is 550 mg three times daily for 14 days. Retreatment is an option for patients who initially respond but relapse [13].<\/p>\n<p><strong>Alosetron (Lotronex):<\/strong> A serotonin 5-HT3 receptor antagonist reserved for severe IBS-D in women who haven&#8217;t responded to other treatments. It&#8217;s effective but carries rare risks of ischemic colitis and severe constipation, so it&#8217;s prescribed under a restricted program [14].<\/p>\n<p><strong>Bile acid sequestrants:<\/strong> Cholestyramine, colesevelam, or colestipol can be transformative for patients with confirmed or suspected bile acid malabsorption. If your diarrhea consistently worsens after fatty meals and especially in the morning, ask your doctor about a bile acid trial [10].<\/p>\n<h3>Dietary Tips for IBS-D<\/h3>\n<p>Reduce insoluble fiber (wheat bran, raw vegetables, nuts with skins) as these can speed transit and worsen diarrhea. Soluble fiber in moderate amounts is still helpful for normalizing stool consistency.<\/p>\n<p>Caffeine and alcohol are common triggers that stimulate colonic motility. Limiting large fatty meals can also help, especially if bile acid issues are suspected. The <a href=\"\/blog\/low-fodmap-diet-guide\">low FODMAP diet<\/a> is effective for both subtypes, but IBS-D patients tend to have particularly strong responses to fructose and polyols [15].<\/p>\n<h2>IBS-M: Living With Both Patterns<\/h2>\n<p>Mixed IBS is perhaps the most frustrating subtype because you can&#8217;t even predict which symptom will dominate on any given day. One week you&#8217;re dealing with constipation, the next it swings to diarrhea, sometimes within the same day.<\/p>\n<p>Treatment for IBS-M focuses on approaches that normalize motility in both directions rather than pushing it one way. Antispasmodics, the low FODMAP diet, peppermint oil, and gut-directed psychological therapies tend to be the most useful first-line options. Doctors are generally cautious about prescribing strong constipation or diarrhea-specific drugs because they can overshoot in the wrong direction.<\/p>\n<p>Low-dose tricyclic antidepressants may help by modulating gut nerve sensitivity, and some evidence suggests they can reduce the amplitude of motility swings [16]. Soluble fiber in small, consistent doses also helps by adding bulk regardless of whether the stool is too loose or too firm.<\/p>\n<h2>When Subtypes Shift<\/h2>\n<p>Here&#8217;s something that surprises many patients: your subtype is not permanent. Research shows that between 25% and 40% of IBS patients change subtypes over a one-year period [17]. Someone diagnosed with IBS-D may gradually shift to IBS-M or even IBS-C, and vice versa.<\/p>\n<p>This is one reason why ongoing communication with your doctor matters. A treatment plan that worked six months ago may need adjustment if your bowel pattern has changed. It&#8217;s also why tracking your symptoms and stool patterns, even briefly, remains useful well after your initial diagnosis.<\/p>\n<p>Factors that can trigger a subtype shift include dietary changes, new medications (especially antibiotics), hormonal fluctuations, significant stress, and changes to your gut microbiome. Women in particular may notice that their subtype shifts across different phases of the menstrual cycle, with <a href=\"\/blog\/ibs-symptoms-in-women\">constipation more common in the luteal phase and diarrhea around menstruation<\/a> [18].<\/p>\n<h2>Getting the Right Diagnosis<\/h2>\n<p>If you haven&#8217;t been formally subtyped, consider keeping a two-week stool diary noting the Bristol type of each bowel movement, along with any associated pain, urgency, or bloating. This gives your gastroenterologist the data they need to make treatment decisions rather than relying on how you feel on a single clinic day.<\/p>\n<p>It&#8217;s also worth mentioning that certain conditions mimic IBS subtypes. Celiac disease and microscopic colitis can look like IBS-D. Pelvic floor dysfunction and slow-transit constipation can look like IBS-C. If subtype-appropriate treatment isn&#8217;t working after a reasonable trial, further testing may be warranted.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the difference between IBS-C and IBS-D?<\/h3>\n<p>In IBS-C (constipation-predominant), more than 25% of bowel movements are hard or lumpy (Bristol types 1-2) and fewer than 25% are loose or watery. In IBS-D (diarrhea-predominant), more than 25% are loose or watery (Bristol types 6-7) and fewer than 25% are hard or lumpy. The distinction matters because your subtype determines which medications are appropriate, which dietary changes are likely to help, and which underlying mechanisms may be driving your symptoms.<\/p>\n<h3>How is IBS subtype diagnosed?<\/h3>\n<p>IBS is diagnosed using the Rome IV criteria, defined as recurrent abdominal pain at least one day per week over the last three months, associated with changes in stool frequency or form. Subtype is determined using the Bristol Stool Form Scale, which sorts stool into seven types, with types 3 and 4 considered normal. The article recommends keeping a two-week stool diary noting the Bristol type of each bowel movement along with any pain, urgency, or bloating.<\/p>\n<h3>What medications are used for IBS-C versus IBS-D?<\/h3>\n<p>For IBS-C, options include linaclotide (Linzess), plecanatide (Trulance), lubiprostone (Amitiza), tegaserod (Zelnorm, re-approved in 2019 for women under 65), and osmotic laxatives like polyethylene glycol (MiraLAX). For IBS-D, options include loperamide (Imodium), eluxadoline (Viberzi), rifaximin (Xifaxan), alosetron (Lotronex), and bile acid sequestrants such as cholestyramine, colesevelam, or colestipol. The right choice depends on your subtype and underlying mechanism.<\/p>\n<h3>What are the side effects and safety concerns with these treatments?<\/h3>\n<p>With lubiprostone (Amitiza), nausea is the most common side effect, and taking it with food helps. Tegaserod is restricted to women under 65 due to earlier cardiovascular concerns. Eluxadoline is contraindicated in patients without a gallbladder. Alosetron carries rare risks of ischemic colitis and severe constipation and is prescribed only under a restricted program, reserved for severe IBS-D in women who have not responded to other treatments.<\/p>\n<h3>Which diet changes help IBS-C and IBS-D?<\/h3>\n<p>For IBS-C, the article points to soluble fiber such as psyllium husk at 5 to 10 grams daily (increased gradually to avoid worsening bloating), two green kiwis daily, which outperformed psyllium in a trial, and adequate hydration since fiber without water can make constipation worse. For IBS-D, it suggests reducing insoluble fiber, limiting caffeine and alcohol, and avoiding large fatty meals. The low FODMAP diet shows response rates up to 80% in clinical trials, and IBS-D patients tend to respond particularly strongly to fructose and polyols.<\/p>\n<h3>Can my IBS subtype change over time?<\/h3>\n<p>Yes. The article states your subtype is not permanent, and that between 25% and 40% of IBS patients change subtypes over a one-year period, with roughly one-third alternating between constipation and diarrhea patterns within the same year. Triggers for shifts include dietary changes, new medications (especially antibiotics), hormonal fluctuations, significant stress, and changes to your gut microbiome. Women may notice shifts across the menstrual cycle, with constipation more common in the luteal phase and diarrhea around menstruation.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the difference between IBS-C and IBS-D?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In IBS-C (constipation-predominant), more than 25% of bowel movements are hard or lumpy (Bristol types 1-2) and fewer than 25% are loose or watery. In IBS-D (diarrhea-predominant), more than 25% are loose or watery (Bristol types 6-7) and fewer than 25% are hard or lumpy. The distinction matters because your subtype determines which medications are appropriate, which dietary changes are likely to help, and which underlying mechanisms may be driving your symptoms.\"}},{\"@type\":\"Question\",\"name\":\"How is IBS subtype diagnosed?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"IBS is diagnosed using the Rome IV criteria, defined as recurrent abdominal pain at least one day per week over the last three months, associated with changes in stool frequency or form. Subtype is determined using the Bristol Stool Form Scale, which sorts stool into seven types, with types 3 and 4 considered normal. The article recommends keeping a two-week stool diary noting the Bristol type of each bowel movement along with any pain, urgency, or bloating.\"}},{\"@type\":\"Question\",\"name\":\"What medications are used for IBS-C versus IBS-D?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For IBS-C, options include linaclotide (Linzess), plecanatide (Trulance), lubiprostone (Amitiza), tegaserod (Zelnorm, re-approved in 2019 for women under 65), and osmotic laxatives like polyethylene glycol (MiraLAX). For IBS-D, options include loperamide (Imodium), eluxadoline (Viberzi), rifaximin (Xifaxan), alosetron (Lotronex), and bile acid sequestrants such as cholestyramine, colesevelam, or colestipol. The right choice depends on your subtype and underlying mechanism.\"}},{\"@type\":\"Question\",\"name\":\"What are the side effects and safety concerns with these treatments?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"With lubiprostone (Amitiza), nausea is the most common side effect, and taking it with food helps. Tegaserod is restricted to women under 65 due to earlier cardiovascular concerns. Eluxadoline is contraindicated in patients without a gallbladder. Alosetron carries rare risks of ischemic colitis and severe constipation and is prescribed only under a restricted program, reserved for severe IBS-D in women who have not responded to other treatments.\"}},{\"@type\":\"Question\",\"name\":\"Which diet changes help IBS-C and IBS-D?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For IBS-C, the article points to soluble fiber such as psyllium husk at 5 to 10 grams daily (increased gradually to avoid worsening bloating), two green kiwis daily, which outperformed psyllium in a trial, and adequate hydration since fiber without water can make constipation worse. For IBS-D, it suggests reducing insoluble fiber, limiting caffeine and alcohol, and avoiding large fatty meals. The low FODMAP diet shows response rates up to 80% in clinical trials, and IBS-D patients tend to respond particularly strongly to fructose and polyols.\"}},{\"@type\":\"Question\",\"name\":\"Can my IBS subtype change over time?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. The article states your subtype is not permanent, and that between 25% and 40% of IBS patients change subtypes over a one-year period, with roughly one-third alternating between constipation and diarrhea patterns within the same year. Triggers for shifts include dietary changes, new medications (especially antibiotics), hormonal fluctuations, significant stress, and changes to your gut microbiome. Women may notice shifts across the menstrual cycle, with constipation more common in the luteal phase and diarrhea around menstruation.\"}}]}<\/script><\/p>\n<h2>References<\/h2>\n<ol>\n<li id=\"ref-1\"><a href=\"\/blog\/ibs\">IBS: The Complete Guide<\/a><\/li>\n<li id=\"ref-2\"><a href=\"\/blog\/ibs-treatment-options\">IBS Treatment Options: Medications, Diet, and Therapies<\/a><\/li>\n<li id=\"ref-3\"><a href=\"\/blog\/ibs-symptoms\">IBS Symptoms You Shouldn&#8217;t Ignore<\/a><\/li>\n<li id=\"ref-4\"><a href=\"\/blog\/ibs-symptoms-in-women\">IBS Symptoms in Women<\/a><\/li>\n<li id=\"ref-5\"><a href=\"\/blog\/low-fodmap-diet-guide\">The Low FODMAP Diet: A Step-by-Step Guide<\/a><\/li>\n<li id=\"ref-6\"><a href=\"\/blog\/ibs-vs-sibo\">IBS vs SIBO: What&#8217;s the Difference?<\/a><\/li>\n<\/ol>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>IBS is not one condition. Whether you deal primarily with constipation (IBS-C), diarrhea (IBS-D), or a frustrating mix of both, your subtype changes which medications, diets, and lifestyle strategies will actually work for you. Here&#8217;s how to tell the difference and what to do about it.<\/p>\n","protected":false},"author":1,"featured_media":6411,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1177],"tags":[1186,1187,1185,1178,1183,1184],"class_list":["post-5881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ibs","tag-constipation","tag-diarrhea","tag-ibs-subtypes","tag-ibs-treatment","tag-ibs-c","tag-ibs-d"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5881"}],"version-history":[{"count":3,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5881\/revisions"}],"predecessor-version":[{"id":6773,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5881\/revisions\/6773"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6411"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}